Coya Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
COYA chart
What traders are saying about $COYA
Latest postsCoya Therapeutics, Inc. news
- Coya Therapeutics, Inc. Estimates – NASDAQ:COYA
TradingView ·
- Coya to Initiate Open-Label Extension of Phase 2/3 ALSTARS Trial of COYA 302 in ALS
Yahoo Finance ·
- Coya Therapeutics Announces Participation at Chardan's 10th Annual Healthcare Conference
Yahoo Finance ·
- Coya Therapeutics Announces Completion of Full Enrollment in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Yahoo Finance ·
- Coya Therapeutics Announces Enrollment of 100th Participant in Phase 2/3 ALSTARS Trial of COYA 302 for the Treatment of ALS
Yahoo Finance ·
- Coya Therapeutics Announces Publication of Preclinical Study Demonstrating Combination Immunomodulatory Effects of COYA 303 in a Well-Established Model of Peripheral and CNS Inflammation
Yahoo Finance ·
- Coya Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update
Yahoo Finance ·
- Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance ·
- Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting
Yahoo Finance ·
- Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease
Yahoo Finance ·
- Coya Therapeutics Announces the First Cohort of Patients in the ALSTARS Trial Have Begun the Blinded Active-Treatment Extension Phase
Yahoo Finance ·
- Coya Therapeutics secures FDA fast track status for COYA 302
pharmaceutical-technology.com ·
Coya Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $7.9M | $3.6M | $6.0M | $0 |
| Net income | -$21.2M | -$14.9M | -$8.0M | -$12.2M |
| Diluted EPS | $-1.27 | $-0.98 | $-0.79 | $-4.73 |
| Total assets (year end) | $50.0M | $44.3M | $41.3M | $8.4M |
| Cash and equivalents (year end) | $46.8M | $38.3M | $32.6M | $5.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Coya Therapeutics, Inc.
- Ticker
- COYA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1835022
Frequently asked questions
What exchange is Coya Therapeutics, Inc. listed on?
Coya Therapeutics, Inc. trades on the Nasdaq under the ticker symbol COYA.
What industry is Coya Therapeutics, Inc. in?
Coya Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Coya Therapeutics, Inc. headquartered?
Coya Therapeutics, Inc.'s business address on file with the SEC is in Houston, TX.
When does Coya Therapeutics, Inc.'s fiscal year end?
Coya Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Coya Therapeutics, Inc. report?
Coya Therapeutics, Inc. reported $7.9M in revenue for calendar year 2025, according to its SEC filings.